Atracurium was studied in day-stay patients undergoing short surgical procedures requiring tracheal intubation. In a dose of 0.2S mg kg' 1 and with an anaesthetic technique using enflurane, tracheal intubation could be performed in all patients within 3 min and was readily reversible, unless the duration of turgery was less than 20 min. The administration of an antagonist was indicated in nearly all patients in whom surgery lasted for less than 30 min.
Increasingly, surgery is being carried out on a daystay basis and it is commonplace for the trachea to be intubated in such patients (Atkinson, 1982) . However, there has been, and perhaps still is, a general reluctance to use neuromuscular blocking drugs in outpatients (Goold, 1983) . This may be attributed partly to the fact that a satisfactory neuromuscular blocking agent has not been available. The administration of suxamethonium is accompanied by an appreciable frequency of muscle pains, especially in patients who return to full ambulation early (Churchill-Davidson, 1954) . Moreover, a single dose is too short for most surgical procedures and repeated doses produce adverse effects on the cardiovascular system and the neuromuscular junction. Competitive myoneural blockade (for example, with tubocurarine or alcuronium) in a dose sufficient for tracheal intubation may be accompanied by profound residual paralysis at the end of surgery.
The short duration of effect of atracurium suggested that it might be useful in these circumstances. Thus, we have studied the use of atracurium 0.25 mg kg" 1 in patients undergoing procedures requiring tracheal intubation, on an out-patient basis.
PATIENTS AND METHODS
The investigation was approved by the Ethics Committee and informed consent was obtained from each patient. Twenty-six patients (ASA I) were studied. Neuromuscular blockade was monitored by recording the force of contraction of the adductor pollicis of the left hand to stimulation of the ulnar nerve at the wrist. The arm was placed in a specially constructed splint and the thumb attached to a Grass FTO3C force displacement transducer before the induction of anaesthesia. A Devices preamplifier and two-channel chart recorder were used to obtain a permanent record of twitch height. Electrical stimulation was with supramaximar-0.2-ms square wave impulses delivered in a train-of-four pattern at 2 Hz every 12 s via surface electrodes (Myotest). A needle was inserted to a vein on the dorsum of the right hand and anaesthesia was induced with 2.5% thiopentone. Following establishment of control train-of-four recordings, atracurium 0.25 mg kg" 1 was administered through the same needle, preceded and followed by a 1-ml saline flush (time Omin). The patient received 3% enflurane (1.8 MAC) in a 1:2 oxygen: nitrous oxide mixture (by mask) utilising a Bain-type coaxial circuit. Ventilation was assisted and then controlled as respiration failed and the fresh gas flow adjusted to a level consistent with normocapnia. The height of the first twitch of the train-of-four (TO was monitored and compared with the height of Ti of the control trainof-four (T^control). Tracheal intubation was carried out when Tiicontrol was 25% or after 3 min, whichever was the shorter time. One of the authors (RMJ) performed all the intubations, and the following assessments of intubating conditions were recorded: (1) jaw relaxation: good or poor; (2) spontaneous movements of the vocal cords before intubation: present or absent, and (3) diaphragmatic movement, cough or both, following intubation: present (with time period) or absent. Following intubation of the trachea the inspired enflurane concentration was decreased to 1% (0.6 MAC). At the end of surgery the degree of neuromuscular blockade was assessed by recording Ti:control and the height of the fourth twitch (T 4 ) to Ti in the same train (T* ratio). If the T 4 ratio was > 0.5, no reversal 
RESULTS
The mean age and mean weight of the study group were 25.8(6.5)yr and 61.5(9.2)kg, respectively. Intubation of the trachea using the criterion of Ti:control 25%, was possible in 11 patients (group A) before 3 min (2.03(0.55)min; range 1.17-2.58min). In the remaining 15 patients (group B) intubation was carried out at 3 min when Tiicontrol was 45% (20%) (table I). It was possible to intubate the trachea of all patients although in two patients, one in each of groups A and B, conditions were almost unacceptable. The age and weight distribution between group A and B were not significantly different (P> 0.05).
It was possible to determine accurately the time of onset and the extent of maximum neuromuscular blockade in 21 patients (table II) . Data relating to the reversal of neuromuscular blockade were divided into three groups according to the duration of the operation: group 1, 14-20 min; group 2, 21-30min and group 3, >31 min (table III). Four of the 10 patients in group 1 had no recordable response to ulnar nerve stimulation at the end of operation. In these four patients, although a T 4 ratio > 0.5 was achieved eventually after administration of the antagonist, recovery was prolonged; two received neostigmine (reversal times 6.0 and 9.0 min) and two received edrophonium (reversal times 8.5 and 7.0 min). In the remaining six patients in group 1, who had at least some response to ulnar nerve stimulation (mean Ti:control 25% (22%); range 8%-63%), reversal of blockade was rapid (< 6.0 min) after the administration of the antagonist drug.
All patients in groups 2 and 3 had some response to ulnar nerve stimulation and reversal of blockade was rapid (< 6.0 min) and reliable if antagonist administration was indicated (T 4 ratio <0.5). Three of the five patients in group 3 and one of the 11 patients in group 2 did not require the administ- 1 with 1-2% enflurane was associated with a time of 52.7 min between the administration of atracurium and the return to a Ti rcontrol of 2 5%, a significantly longer time than for the same dose of atracurium with neuroleptanaesthesia (41.7 min) (Nguyen et al., 1982) . In another study, atracurium 0.33 mg kg" 1 without enflurane caused depression of the twitch height to below 25% of control for 27.6 min (Gramstad, T.illeaasen and Minsaas, 1982). It was noticeable in our study that some patients resumed breathing with a clinically acceptable tidal volume when the twitch response was still markedly depressed before antagonism. Thus, resumption of spontaneous breathing with a tracheal tube in situ is not evidence that spontaneous reversal from atracurium has occurred to a degree which obviates the need for anticholinesterases. In our study, pharmacological reversal with either edrophonium or neostigmine was always possible although, if the operation lasted less than 20 min, reversal was sometimes delayed. Extubation of the trachea at a T 4 ratio of 0.5 was always associated with clinically good reversal in the recovery area, although this ratio was lower than that previously suggested to correlate with good clinical reversal (Ali and Kitz, 1973).
There was no clinical evidence of recurarization.
The relatively large doses of competitive neuromuscular blocking drugs required to facilitate tracheal intubation in day-stay patients (whose operations are often of short duration) directly oppose the requirement for rapid and reliable pharmacological reversal at the end of operation. We believe that a dose of atracurium 0.25mgkg~' represents a good compromise between these mutually exclusive aims.
In summary, we believe that atracurium possesses many of the characteristics of an ideal neuromuscular blocker for use in day-stay surgery. In conjunction with the anaesthetic technique described, a dose of 0.25 mg kg" 1 provided perfect conditions for tracheal intubation in about 50% of patients and acceptable conditions in the majority of the remainder. Unless surgery is very brief (<20min), rapid reversal of residual neuromuscular blockade is achieved reliably. However, we have demonstrated that, unless surgery lasts in excess of 30min, the administration of antagonist is nearly always indicated. Routine monitoring of the degree of neuromuscular blockade allows a considered decision to be made on the requirement or otherwise for an antagonist.
